Advanced Cell Technology touts positive trial results of stem cell therapy

04/26/2010 | Mass High Tech (Boston)

Advanced Cell Technology reported that its Stargardt's macular dystrophy treatment, which uses retinal pigment epithelium cells, did not cause any side effects in animal subjects. The biotech firm plans to launch human trials of the stem cell therapy in Oregon, New Jersey and Massachusetts.

View Full Article in:

Mass High Tech (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
Bend, OR
Clinical Appeals RN
Brooklyn, NY
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ